JP2004504399A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504399A5
JP2004504399A5 JP2002514137A JP2002514137A JP2004504399A5 JP 2004504399 A5 JP2004504399 A5 JP 2004504399A5 JP 2002514137 A JP2002514137 A JP 2002514137A JP 2002514137 A JP2002514137 A JP 2002514137A JP 2004504399 A5 JP2004504399 A5 JP 2004504399A5
Authority
JP
Japan
Prior art keywords
branched
straight
substituents
carbon atoms
saturated alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002514137A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504399A (ja
JP4980542B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/023633 external-priority patent/WO2002008231A2/en
Publication of JP2004504399A publication Critical patent/JP2004504399A/ja
Publication of JP2004504399A5 publication Critical patent/JP2004504399A5/ja
Application granted granted Critical
Publication of JP4980542B2 publication Critical patent/JP4980542B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002514137A 2000-07-24 2001-07-24 生物活性マクロライド、組成物、及びそれらの使用 Expired - Fee Related JP4980542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22027000P 2000-07-24 2000-07-24
US60/220,270 2000-07-24
PCT/US2001/023633 WO2002008231A2 (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof

Publications (3)

Publication Number Publication Date
JP2004504399A JP2004504399A (ja) 2004-02-12
JP2004504399A5 true JP2004504399A5 (enExample) 2008-09-04
JP4980542B2 JP4980542B2 (ja) 2012-07-18

Family

ID=22822844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002514137A Expired - Fee Related JP4980542B2 (ja) 2000-07-24 2001-07-24 生物活性マクロライド、組成物、及びそれらの使用

Country Status (8)

Country Link
US (5) US7144918B2 (enExample)
EP (1) EP1303522B1 (enExample)
JP (1) JP4980542B2 (enExample)
AT (1) ATE504589T1 (enExample)
AU (2) AU8083401A (enExample)
CA (1) CA2415611C (enExample)
DE (1) DE60144376D1 (enExample)
WO (1) WO2002008231A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8083401A (en) * 2000-07-24 2002-02-05 Us Health Biologically active macrolides, compositions, and uses thereof
WO2004009079A1 (en) 2002-07-24 2004-01-29 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
WO2010144611A2 (en) * 2009-06-10 2010-12-16 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000053B1 (en) * 1997-07-25 2004-06-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Macrocyclic lactones, compositions, and methods of use
US7381744B1 (en) 1999-03-05 2008-06-03 The United States Of America As Represented By The Department Of Health And Human Services Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
AU8083401A (en) * 2000-07-24 2002-02-05 Us Health Biologically active macrolides, compositions, and uses thereof

Similar Documents

Publication Publication Date Title
CA2494049A1 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
KR950000728A (ko) 포스포네이트 뉴클레오티드 에스테르 유도체
JP2002539152A5 (enExample)
RU2000127751A (ru) Противоопухолевое средство
KR890701562A (ko) 면역조절 아자스 피란류
KR920009796A (ko) 3-아미도인돌릴 유도체
CA2415010A1 (en) Propane-1,3-dione derivatives useful as gnrh receptor antagonist
JP2003519176A5 (enExample)
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
CA2126465C (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
JP2004531544A5 (enExample)
EP1108428A3 (en) Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
RU2006101987A (ru) Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции
RU2002123641A (ru) С-4 карбонатсодержащие таксаны
RU2003134629A (ru) Соединения цефема
KR950703941A (ko) 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
KR910018383A (ko) 종양성 질환 치료용 엽산염 및 항엽산염과의 디플루오로글루 탐산 공역체
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
KR940009184A (ko) 피라졸 축합환 유도체, 이의 제조방법 및 안드로겐 억제제
JPH1036365A5 (enExample)
EP0210753A3 (en) Anti-tumor medicament
JP2004504399A5 (enExample)
RU96103685A (ru) 1,2,5-тиадиазольные производные индолилалкил-пиридинил- и пиримидинил-пиперазинов, способ лечения или предотвращения развития сосудистой головной боли и фармацевтическая композиция